If you haven’t been following the recent line of credit issued to Medmen, Alex Berenson wrote a great piece covering it for CNBC here. Some of the challenges facing the company based on their burn rate, asset sales, and overall competition from legal and black-market suppliers, most notably in California, could spell trouble for the company. Berenson, reports on the “credit card like deal”, as I will call it, that Medmen made with Gotham Green partners. Some of the highlights, lowlights if you are a shareholder, include the following:
No comments:
Post a Comment